nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamotrigine—Mouth ulceration—Methotrexate—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Lamotrigine—Urine output increased—Methotrexate—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Lamotrigine—Bladder pain—Methotrexate—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Lamotrigine—Alopecia—Mitoxantrone—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Lamotrigine—Confusional state—Bleomycin—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Lamotrigine—Vision blurred—Carmustine—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Lamotrigine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Lamotrigine—Tremor—Carmustine—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Lamotrigine—Oedema—Bleomycin—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Lamotrigine—Erythema—Mitoxantrone—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Lamotrigine—Infection—Bleomycin—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Lamotrigine—Anaemia—Carmustine—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Lamotrigine—Back pain—Vincristine—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Lamotrigine—Vomiting—Teniposide—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Lamotrigine—Agitation—Carmustine—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Lamotrigine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Lamotrigine—Asthenia—Fludarabine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Lamotrigine—Rash—Teniposide—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Lamotrigine—Dermatitis—Teniposide—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Lamotrigine—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Lamotrigine—Headache—Teniposide—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Lamotrigine—Pruritus—Fludarabine—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Lamotrigine—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Lamotrigine—Back pain—Mitoxantrone—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Lamotrigine—Leukopenia—Carmustine—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Lamotrigine—Anorexia—Bleomycin—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Lamotrigine—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Lamotrigine—Anaemia—Vincristine—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Lamotrigine—Agitation—Vincristine—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Lamotrigine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Lamotrigine—Photosensitivity—Methotrexate—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Lamotrigine—Polyuria—Methotrexate—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Lamotrigine—Diarrhoea—Fludarabine—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Lamotrigine—Convulsion—Carmustine—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Lamotrigine—Hypertension—Carmustine—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Lamotrigine—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Lamotrigine—Nausea—Teniposide—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Lamotrigine—Anaemia—Mitoxantrone—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Lamotrigine—Vertigo—Vincristine—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Lamotrigine—Hepatic failure—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Lamotrigine—Leukopenia—Vincristine—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Lamotrigine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Lamotrigine—Chest pain—Carmustine—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Lamotrigine—Myalgia—Carmustine—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Lamotrigine—Anxiety—Carmustine—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Lamotrigine—Paraesthesia—Bleomycin—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Lamotrigine—Malaise—Mitoxantrone—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Lamotrigine—Dyspnoea—Bleomycin—lymphatic system cancer	0.001	0.001	CcSEcCtD
Lamotrigine—Renal failure acute—Methotrexate—lymphatic system cancer	0.001	0.001	CcSEcCtD
Lamotrigine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.001	0.001	CcSEcCtD
Lamotrigine—Convulsion—Vincristine—lymphatic system cancer	0.000997	0.000997	CcSEcCtD
Lamotrigine—Hypertension—Vincristine—lymphatic system cancer	0.000994	0.000994	CcSEcCtD
Lamotrigine—Confusional state—Carmustine—lymphatic system cancer	0.000992	0.000992	CcSEcCtD
Lamotrigine—Oedema—Carmustine—lymphatic system cancer	0.000984	0.000984	CcSEcCtD
Lamotrigine—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000983	0.000983	CcSEcCtD
Lamotrigine—Decreased appetite—Bleomycin—lymphatic system cancer	0.00098	0.00098	CcSEcCtD
Lamotrigine—Myalgia—Vincristine—lymphatic system cancer	0.00098	0.00098	CcSEcCtD
Lamotrigine—Cough—Mitoxantrone—lymphatic system cancer	0.000978	0.000978	CcSEcCtD
Lamotrigine—Infection—Carmustine—lymphatic system cancer	0.000978	0.000978	CcSEcCtD
Lamotrigine—Vomiting—Fludarabine—lymphatic system cancer	0.000978	0.000978	CcSEcCtD
Lamotrigine—Convulsion—Mitoxantrone—lymphatic system cancer	0.000971	0.000971	CcSEcCtD
Lamotrigine—Rash—Fludarabine—lymphatic system cancer	0.000969	0.000969	CcSEcCtD
Lamotrigine—Dermatitis—Fludarabine—lymphatic system cancer	0.000968	0.000968	CcSEcCtD
Lamotrigine—Hypertension—Mitoxantrone—lymphatic system cancer	0.000968	0.000968	CcSEcCtD
Lamotrigine—Pain—Bleomycin—lymphatic system cancer	0.000964	0.000964	CcSEcCtD
Lamotrigine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000963	0.000963	CcSEcCtD
Lamotrigine—Headache—Fludarabine—lymphatic system cancer	0.000963	0.000963	CcSEcCtD
Lamotrigine—Tachycardia—Carmustine—lymphatic system cancer	0.00096	0.00096	CcSEcCtD
Lamotrigine—Chest pain—Mitoxantrone—lymphatic system cancer	0.000954	0.000954	CcSEcCtD
Lamotrigine—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000954	0.000954	CcSEcCtD
Lamotrigine—Myalgia—Mitoxantrone—lymphatic system cancer	0.000954	0.000954	CcSEcCtD
Lamotrigine—Anxiety—Mitoxantrone—lymphatic system cancer	0.000951	0.000951	CcSEcCtD
Lamotrigine—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000946	0.000946	CcSEcCtD
Lamotrigine—Discomfort—Mitoxantrone—lymphatic system cancer	0.000943	0.000943	CcSEcCtD
Lamotrigine—Oedema—Vincristine—lymphatic system cancer	0.000939	0.000939	CcSEcCtD
Lamotrigine—Anorexia—Carmustine—lymphatic system cancer	0.000938	0.000938	CcSEcCtD
Lamotrigine—Infection—Vincristine—lymphatic system cancer	0.000933	0.000933	CcSEcCtD
Lamotrigine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000929	0.000929	CcSEcCtD
Lamotrigine—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000927	0.000927	CcSEcCtD
Lamotrigine—Confusional state—Mitoxantrone—lymphatic system cancer	0.000922	0.000922	CcSEcCtD
Lamotrigine—Nervous system disorder—Vincristine—lymphatic system cancer	0.000921	0.000921	CcSEcCtD
Lamotrigine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00092	0.00092	CcSEcCtD
Lamotrigine—Oedema—Mitoxantrone—lymphatic system cancer	0.000915	0.000915	CcSEcCtD
Lamotrigine—Nausea—Fludarabine—lymphatic system cancer	0.000913	0.000913	CcSEcCtD
Lamotrigine—Infection—Mitoxantrone—lymphatic system cancer	0.000909	0.000909	CcSEcCtD
Lamotrigine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000908	0.000908	CcSEcCtD
Lamotrigine—Shock—Mitoxantrone—lymphatic system cancer	0.0009	0.0009	CcSEcCtD
Lamotrigine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000896	0.000896	CcSEcCtD
Lamotrigine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000896	0.000896	CcSEcCtD
Lamotrigine—Urticaria—Bleomycin—lymphatic system cancer	0.000895	0.000895	CcSEcCtD
Lamotrigine—Anorexia—Vincristine—lymphatic system cancer	0.000895	0.000895	CcSEcCtD
Lamotrigine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000893	0.000893	CcSEcCtD
Lamotrigine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000891	0.000891	CcSEcCtD
Lamotrigine—Insomnia—Carmustine—lymphatic system cancer	0.00089	0.00089	CcSEcCtD
Lamotrigine—Irritability—Methotrexate—lymphatic system cancer	0.000885	0.000885	CcSEcCtD
Lamotrigine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000884	0.000884	CcSEcCtD
Lamotrigine—Paraesthesia—Carmustine—lymphatic system cancer	0.000884	0.000884	CcSEcCtD
Lamotrigine—Mood swings—Methotrexate—lymphatic system cancer	0.000878	0.000878	CcSEcCtD
Lamotrigine—Dyspnoea—Carmustine—lymphatic system cancer	0.000877	0.000877	CcSEcCtD
Lamotrigine—Somnolence—Carmustine—lymphatic system cancer	0.000875	0.000875	CcSEcCtD
Lamotrigine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000872	0.000872	CcSEcCtD
Lamotrigine—Ataxia—Methotrexate—lymphatic system cancer	0.000872	0.000872	CcSEcCtD
Lamotrigine—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000856	0.000856	CcSEcCtD
Lamotrigine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000856	0.000856	CcSEcCtD
Lamotrigine—Decreased appetite—Carmustine—lymphatic system cancer	0.000855	0.000855	CcSEcCtD
Lamotrigine—Insomnia—Vincristine—lymphatic system cancer	0.00085	0.00085	CcSEcCtD
Lamotrigine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000849	0.000849	CcSEcCtD
Lamotrigine—Paraesthesia—Vincristine—lymphatic system cancer	0.000843	0.000843	CcSEcCtD
Lamotrigine—Constipation—Carmustine—lymphatic system cancer	0.000841	0.000841	CcSEcCtD
Lamotrigine—Pain—Carmustine—lymphatic system cancer	0.000841	0.000841	CcSEcCtD
Lamotrigine—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000835	0.000835	CcSEcCtD
Lamotrigine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000833	0.000833	CcSEcCtD
Lamotrigine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00083	0.00083	CcSEcCtD
Lamotrigine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000821	0.000821	CcSEcCtD
Lamotrigine—Decreased appetite—Vincristine—lymphatic system cancer	0.000817	0.000817	CcSEcCtD
Lamotrigine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000816	0.000816	CcSEcCtD
Lamotrigine—Somnolence—Mitoxantrone—lymphatic system cancer	0.000813	0.000813	CcSEcCtD
Lamotrigine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000811	0.000811	CcSEcCtD
Lamotrigine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000811	0.000811	CcSEcCtD
Lamotrigine—Fatigue—Vincristine—lymphatic system cancer	0.00081	0.00081	CcSEcCtD
Lamotrigine—Asthenia—Bleomycin—lymphatic system cancer	0.000809	0.000809	CcSEcCtD
Lamotrigine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000805	0.000805	CcSEcCtD
Lamotrigine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000805	0.000805	CcSEcCtD
Lamotrigine—Pain—Vincristine—lymphatic system cancer	0.000803	0.000803	CcSEcCtD
Lamotrigine—Constipation—Vincristine—lymphatic system cancer	0.000803	0.000803	CcSEcCtD
Lamotrigine—Asthma—Methotrexate—lymphatic system cancer	0.000801	0.000801	CcSEcCtD
Lamotrigine—Pruritus—Bleomycin—lymphatic system cancer	0.000798	0.000798	CcSEcCtD
Lamotrigine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000795	0.000795	CcSEcCtD
Lamotrigine—Eosinophilia—Methotrexate—lymphatic system cancer	0.000794	0.000794	CcSEcCtD
Lamotrigine—Fatigue—Mitoxantrone—lymphatic system cancer	0.000789	0.000789	CcSEcCtD
Lamotrigine—Pancreatitis—Methotrexate—lymphatic system cancer	0.000786	0.000786	CcSEcCtD
Lamotrigine—Pain—Mitoxantrone—lymphatic system cancer	0.000782	0.000782	CcSEcCtD
Lamotrigine—Constipation—Mitoxantrone—lymphatic system cancer	0.000782	0.000782	CcSEcCtD
Lamotrigine—Abdominal pain—Carmustine—lymphatic system cancer	0.000778	0.000778	CcSEcCtD
Lamotrigine—Body temperature increased—Carmustine—lymphatic system cancer	0.000778	0.000778	CcSEcCtD
Lamotrigine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000768	0.000768	CcSEcCtD
Lamotrigine—Pancytopenia—Methotrexate—lymphatic system cancer	0.000761	0.000761	CcSEcCtD
Lamotrigine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000754	0.000754	CcSEcCtD
Lamotrigine—Neutropenia—Methotrexate—lymphatic system cancer	0.000749	0.000749	CcSEcCtD
Lamotrigine—Dysuria—Methotrexate—lymphatic system cancer	0.000749	0.000749	CcSEcCtD
Lamotrigine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000748	0.000748	CcSEcCtD
Lamotrigine—Body temperature increased—Vincristine—lymphatic system cancer	0.000743	0.000743	CcSEcCtD
Lamotrigine—Abdominal pain—Vincristine—lymphatic system cancer	0.000743	0.000743	CcSEcCtD
Lamotrigine—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000738	0.000738	CcSEcCtD
Lamotrigine—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000732	0.000732	CcSEcCtD
Lamotrigine—Urticaria—Mitoxantrone—lymphatic system cancer	0.000727	0.000727	CcSEcCtD
Lamotrigine—Hypersensitivity—Carmustine—lymphatic system cancer	0.000725	0.000725	CcSEcCtD
Lamotrigine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000723	0.000723	CcSEcCtD
Lamotrigine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000723	0.000723	CcSEcCtD
Lamotrigine—Pneumonia—Methotrexate—lymphatic system cancer	0.000719	0.000719	CcSEcCtD
Lamotrigine—Vomiting—Bleomycin—lymphatic system cancer	0.000717	0.000717	CcSEcCtD
Lamotrigine—Infestation NOS—Methotrexate—lymphatic system cancer	0.000715	0.000715	CcSEcCtD
Lamotrigine—Infestation—Methotrexate—lymphatic system cancer	0.000715	0.000715	CcSEcCtD
Lamotrigine—Drowsiness—Methotrexate—lymphatic system cancer	0.000715	0.000715	CcSEcCtD
Lamotrigine—Depression—Methotrexate—lymphatic system cancer	0.000713	0.000713	CcSEcCtD
Lamotrigine—Rash—Bleomycin—lymphatic system cancer	0.000711	0.000711	CcSEcCtD
Lamotrigine—Dermatitis—Bleomycin—lymphatic system cancer	0.00071	0.00071	CcSEcCtD
Lamotrigine—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000708	0.000708	CcSEcCtD
Lamotrigine—Asthenia—Carmustine—lymphatic system cancer	0.000706	0.000706	CcSEcCtD
Lamotrigine—Renal failure—Methotrexate—lymphatic system cancer	0.000702	0.000702	CcSEcCtD
Lamotrigine—Stomatitis—Methotrexate—lymphatic system cancer	0.000697	0.000697	CcSEcCtD
Lamotrigine—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000695	0.000695	CcSEcCtD
Lamotrigine—Hypersensitivity—Vincristine—lymphatic system cancer	0.000692	0.000692	CcSEcCtD
Lamotrigine—Sweating—Methotrexate—lymphatic system cancer	0.000685	0.000685	CcSEcCtD
Lamotrigine—Haematuria—Methotrexate—lymphatic system cancer	0.000681	0.000681	CcSEcCtD
Lamotrigine—Epistaxis—Methotrexate—lymphatic system cancer	0.000674	0.000674	CcSEcCtD
Lamotrigine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000674	0.000674	CcSEcCtD
Lamotrigine—Asthenia—Vincristine—lymphatic system cancer	0.000674	0.000674	CcSEcCtD
Lamotrigine—Diarrhoea—Carmustine—lymphatic system cancer	0.000673	0.000673	CcSEcCtD
Lamotrigine—Nausea—Bleomycin—lymphatic system cancer	0.00067	0.00067	CcSEcCtD
Lamotrigine—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000667	0.000667	CcSEcCtD
Lamotrigine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000656	0.000656	CcSEcCtD
Lamotrigine—Dizziness—Carmustine—lymphatic system cancer	0.000651	0.000651	CcSEcCtD
Lamotrigine—Haemoglobin—Methotrexate—lymphatic system cancer	0.000645	0.000645	CcSEcCtD
Lamotrigine—Diarrhoea—Vincristine—lymphatic system cancer	0.000643	0.000643	CcSEcCtD
Lamotrigine—Haemorrhage—Methotrexate—lymphatic system cancer	0.000641	0.000641	CcSEcCtD
Lamotrigine—Hepatitis—Methotrexate—lymphatic system cancer	0.000641	0.000641	CcSEcCtD
Lamotrigine—Pharyngitis—Methotrexate—lymphatic system cancer	0.000637	0.000637	CcSEcCtD
Lamotrigine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000626	0.000626	CcSEcCtD
Lamotrigine—Vomiting—Carmustine—lymphatic system cancer	0.000626	0.000626	CcSEcCtD
Lamotrigine—Dizziness—Vincristine—lymphatic system cancer	0.000621	0.000621	CcSEcCtD
Lamotrigine—Rash—Carmustine—lymphatic system cancer	0.00062	0.00062	CcSEcCtD
Lamotrigine—Dermatitis—Carmustine—lymphatic system cancer	0.00062	0.00062	CcSEcCtD
Lamotrigine—Headache—Carmustine—lymphatic system cancer	0.000616	0.000616	CcSEcCtD
Lamotrigine—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000607	0.000607	CcSEcCtD
Lamotrigine—Eye disorder—Methotrexate—lymphatic system cancer	0.000599	0.000599	CcSEcCtD
Lamotrigine—Tinnitus—Methotrexate—lymphatic system cancer	0.000598	0.000598	CcSEcCtD
Lamotrigine—Vomiting—Vincristine—lymphatic system cancer	0.000597	0.000597	CcSEcCtD
Lamotrigine—Rash—Vincristine—lymphatic system cancer	0.000592	0.000592	CcSEcCtD
Lamotrigine—Dermatitis—Vincristine—lymphatic system cancer	0.000592	0.000592	CcSEcCtD
Lamotrigine—Headache—Vincristine—lymphatic system cancer	0.000588	0.000588	CcSEcCtD
Lamotrigine—Nausea—Carmustine—lymphatic system cancer	0.000584	0.000584	CcSEcCtD
Lamotrigine—Angiopathy—Methotrexate—lymphatic system cancer	0.000582	0.000582	CcSEcCtD
Lamotrigine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000582	0.000582	CcSEcCtD
Lamotrigine—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000578	0.000578	CcSEcCtD
Lamotrigine—Rash—Mitoxantrone—lymphatic system cancer	0.000577	0.000577	CcSEcCtD
Lamotrigine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000576	0.000576	CcSEcCtD
Lamotrigine—Chills—Methotrexate—lymphatic system cancer	0.000576	0.000576	CcSEcCtD
Lamotrigine—Headache—Mitoxantrone—lymphatic system cancer	0.000573	0.000573	CcSEcCtD
Lamotrigine—Alopecia—Methotrexate—lymphatic system cancer	0.000567	0.000567	CcSEcCtD
Lamotrigine—Mental disorder—Methotrexate—lymphatic system cancer	0.000562	0.000562	CcSEcCtD
Lamotrigine—Malnutrition—Methotrexate—lymphatic system cancer	0.000558	0.000558	CcSEcCtD
Lamotrigine—Erythema—Methotrexate—lymphatic system cancer	0.000558	0.000558	CcSEcCtD
Lamotrigine—Nausea—Vincristine—lymphatic system cancer	0.000558	0.000558	CcSEcCtD
Lamotrigine—Dysgeusia—Methotrexate—lymphatic system cancer	0.000547	0.000547	CcSEcCtD
Lamotrigine—Nausea—Mitoxantrone—lymphatic system cancer	0.000543	0.000543	CcSEcCtD
Lamotrigine—Back pain—Methotrexate—lymphatic system cancer	0.00054	0.00054	CcSEcCtD
Lamotrigine—Vision blurred—Methotrexate—lymphatic system cancer	0.000526	0.000526	CcSEcCtD
Lamotrigine—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000518	0.000518	CcSEcCtD
Lamotrigine—Anaemia—Methotrexate—lymphatic system cancer	0.000516	0.000516	CcSEcCtD
Lamotrigine—Malaise—Methotrexate—lymphatic system cancer	0.000504	0.000504	CcSEcCtD
Lamotrigine—Vertigo—Methotrexate—lymphatic system cancer	0.000502	0.000502	CcSEcCtD
Lamotrigine—Leukopenia—Methotrexate—lymphatic system cancer	0.0005	0.0005	CcSEcCtD
Lamotrigine—Cough—Methotrexate—lymphatic system cancer	0.000487	0.000487	CcSEcCtD
Lamotrigine—Convulsion—Methotrexate—lymphatic system cancer	0.000484	0.000484	CcSEcCtD
Lamotrigine—Chest pain—Methotrexate—lymphatic system cancer	0.000475	0.000475	CcSEcCtD
Lamotrigine—Arthralgia—Methotrexate—lymphatic system cancer	0.000475	0.000475	CcSEcCtD
Lamotrigine—Myalgia—Methotrexate—lymphatic system cancer	0.000475	0.000475	CcSEcCtD
Lamotrigine—Discomfort—Methotrexate—lymphatic system cancer	0.00047	0.00047	CcSEcCtD
Lamotrigine—Confusional state—Methotrexate—lymphatic system cancer	0.00046	0.00046	CcSEcCtD
Lamotrigine—Infection—Methotrexate—lymphatic system cancer	0.000453	0.000453	CcSEcCtD
Lamotrigine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000447	0.000447	CcSEcCtD
Lamotrigine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000446	0.000446	CcSEcCtD
Lamotrigine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000441	0.000441	CcSEcCtD
Lamotrigine—Anorexia—Methotrexate—lymphatic system cancer	0.000434	0.000434	CcSEcCtD
Lamotrigine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000415	0.000415	CcSEcCtD
Lamotrigine—Insomnia—Methotrexate—lymphatic system cancer	0.000412	0.000412	CcSEcCtD
Lamotrigine—Paraesthesia—Methotrexate—lymphatic system cancer	0.000409	0.000409	CcSEcCtD
Lamotrigine—Dyspnoea—Methotrexate—lymphatic system cancer	0.000406	0.000406	CcSEcCtD
Lamotrigine—Somnolence—Methotrexate—lymphatic system cancer	0.000405	0.000405	CcSEcCtD
Lamotrigine—Dyspepsia—Methotrexate—lymphatic system cancer	0.000401	0.000401	CcSEcCtD
Lamotrigine—Decreased appetite—Methotrexate—lymphatic system cancer	0.000396	0.000396	CcSEcCtD
Lamotrigine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000393	0.000393	CcSEcCtD
Lamotrigine—Fatigue—Methotrexate—lymphatic system cancer	0.000393	0.000393	CcSEcCtD
Lamotrigine—Pain—Methotrexate—lymphatic system cancer	0.00039	0.00039	CcSEcCtD
Lamotrigine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000376	0.000376	CcSEcCtD
Lamotrigine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000373	0.000373	CcSEcCtD
Lamotrigine—Urticaria—Methotrexate—lymphatic system cancer	0.000362	0.000362	CcSEcCtD
Lamotrigine—Abdominal pain—Methotrexate—lymphatic system cancer	0.00036	0.00036	CcSEcCtD
Lamotrigine—Body temperature increased—Methotrexate—lymphatic system cancer	0.00036	0.00036	CcSEcCtD
Lamotrigine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000336	0.000336	CcSEcCtD
Lamotrigine—Asthenia—Methotrexate—lymphatic system cancer	0.000327	0.000327	CcSEcCtD
Lamotrigine—Pruritus—Methotrexate—lymphatic system cancer	0.000322	0.000322	CcSEcCtD
Lamotrigine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000312	0.000312	CcSEcCtD
Lamotrigine—Dizziness—Methotrexate—lymphatic system cancer	0.000301	0.000301	CcSEcCtD
Lamotrigine—Vomiting—Methotrexate—lymphatic system cancer	0.00029	0.00029	CcSEcCtD
Lamotrigine—Rash—Methotrexate—lymphatic system cancer	0.000287	0.000287	CcSEcCtD
Lamotrigine—Dermatitis—Methotrexate—lymphatic system cancer	0.000287	0.000287	CcSEcCtD
Lamotrigine—Headache—Methotrexate—lymphatic system cancer	0.000286	0.000286	CcSEcCtD
Lamotrigine—Nausea—Methotrexate—lymphatic system cancer	0.000271	0.000271	CcSEcCtD
